In today's fireside chat , Michael Betel, President and Founder of the Fatty Liver Alliance, and Professor @GiadaSebastiani, Hepatologist at @mcgillu, explore the comprehensive management of fatty liver disease, now termed MASLD, and reflect on her recently published perspective paper, "Integrating behavioral interventions into a holistic approach to metabolic dysfunction-associated steatotic liver disease". Giada Sebastiani emphasized the necessity of a holistic, multidisciplinary approach to treating MASLD, acknowledging the complexity of the disease that affects multiple systems beyond the liver. She highlighted the recent approval of Rezdiffra for treating MASH in the U.S., which should be complemented with lifestyle changes such as diet and exercise. Dr. Sebastiani underscored that while pharmacological solutions are crucial, they must be integrated with behavioral interventions and lifestyle modifications to be truly effective. Here are the three key takeaways from the discussion: 1. Holistic and Multidisciplinary Approach: Effective management of MASLD requires a comprehensive approach that integrates pharmacological treatments with lifestyle modifications such as diet, exercise, and behavioral interventions. Addressing the disease's multifaceted nature, which affects multiple systems beyond the liver, is essential for improving patient outcomes. 2. Early Intervention and Personalized Care: Early intervention targeting upstream issues like obesity, type 2 diabetes, and eating disorders is crucial in preventing the progression of MASLD. Personalized care tailored to individual patient characteristics enhances the effectiveness of treatment and promotes better health outcomes. 3. Patient Education and Advocacy: Empowering patients with knowledge about MASLD and available treatment options is vital for enabling informed decision-making and encouraging early diagnosis and intervention. Increased awareness and advocacy efforts are essential for improving the management of MASLD and supporting affected individuals. Link to blog with video: fattyliver.ca/blog/f/masld-p… @livertwitter @liverX

Dr. Mark Swain, Hepatologist answers an audience question at our Calgary event and shares one real world patient story about Ozempic and the impact it had on their life and daily routine. #livertwitter #liverX @novonordisk @AASLDtweets @EASLnews @CASLupdates @CanNASHNetwork fattyliver.ca/blog/f/ozempic…

Millions are affected by fatty liver disease, and raising awareness is crucial. Wendy Schaufert has dedicated 10 years to working with patients, focusing on metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH), formerly NAFLD/NASH. Key takeaways: from this excellent video: youtu.be/pyDY53eecQQ 1. Risk Factors: Obesity, diabetes, and insulin resistance significantly increase the risk of developing MASLD and MASH. 2. Diagnosis: Often silent, the disease is usually detected through routine blood work, ultrasounds, and non-invasive liver stiffness tests like SWI and FibroScan. 3. Management: Lifestyle changes, including weight loss, exercise, and healthy eating, are vital. Even a 5-10% weight loss can make a significant difference. 4. Heart Health: Those with fatty liver disease are at a higher risk of heart-related issues. 5. Awareness and Advocacy: Early detection and management can prevent progression to severe liver conditions like cirrhosis. Education and support are essential. Wendy's work and resources like we offer on our Fatty Liver Alliance website, offer valuable information to help manage and understand this condition better. Let's continue to advocate for awareness and healthier lifestyles! #GlobalFattyLiverDay #FattyLiverDisease #MASLD #MASH #HealthAwareness #LiverHealth #PatientAdvocacy @AASLDtweets @easl @CASLupdates @CanNASHNetwork @LiverNurseCA @FamPhysicians @CIHR_IRSC @GlobalLiver @ISGLOBALorg Link to video: youtu.be/pyDY53eecQQ

Dr. Mark Swain, at our Calgary Your Liver, Your Health community education event anwers these 2 attendee questions: 1. Who should be assessed for liver disease? 2. How does your clinic assess for fatty liver disease? Video: youtu.be/cAS_Duepslk #livertwitter @CASLupdates @CIHR_IRSC @CanNASHNetwork

We had an incredible event on June 13, 2024, for #GlobalFattyLiverDay! It was a privilege to host such a knowledgeable and engaged community in Calgary. As the President and Founder of the Fatty Liver Alliance, I’m thrilled to share some highlights and key takeaways from our first presentation titled "Your Liver, Your Health: Understanding Metabolic Dysfunction." Video #1 Key Takeaways: Personal Health Journey: I (@betelm) shared my own experience with fatty liver and emphasized the importance of early detection and lifestyle changes. Educational Outreach: The Fatty Liver Alliance offers a wealth of resources, including expert videos, patient portals, and blogs to help visitors understand and manage their condition. Collaboration and Advocacy: We are committed to working with healthcare professionals, organizations, and the community to raise awareness, influence policy changes, and improve patient care. Benefits of attending in person and watching this video: 1. Increased Awareness: Gain a comprehensive understanding of fatty liver disease and its impact on health. 2. Expert Knowledge: Listen to our next videos and hear about the latest research and insights from top experts, including Dr. Mark Swain and Wendy Schaufert. 3. Proactive Health Management: Learn practical advice on early detection and lifestyle changes. 4. Community Support: Connect with a supportive network of individuals and organizations dedicated to liver health. Let’s continue to raise awareness, educate, and support each other in the fight against fatty liver disease. Together, we can make a difference! #liverx #liverTwitter Thank you to our sponsors: @novonordisk, KNS Canada Inc., @MadrigalPharma, @Echosens, @SiemensHealth, @GlobalLiver, and of course to @CanNASHNetwork and @casl for their partnerships.

What do MASLD and MASH look and feel like? Watch how a community engages with a realistic liver model at our recent community liver health education and screening event. Liam Swain (recently accepted into medical school) interacts closely wth a very curious group of attendees to our Global Fatty Liver Day event. @MadrigalPharma #liverx #livertwitter @EASLnews @AASLDtweets @CASLupdates @CIHR_IRSC @CanNASHNetwork @MarkDonnison @supriyajoshiMD

Global Fatty Liver Day was a huge success in the Calgary, AB community with 60 attendees and 33 Fibroscan assessments. A HUGE thank you to @novonordisk, @GlobalLiver, @Echosens, @SiemensHealth, KNS Canada Inc. and @MadrigalPharma for their support. Dr. Mark Swain, Wendy Schaufert, Jordyn Vienneau, Liam Swain and Mark Miller thank you for being there and for your contributions. @TonyVilliotti, your liver journey was inspirational. Fahmida Rahman, your relentless work getting so many assessments done and coming all the way to Calgary with a colleague and 2 Fibroscans was very much appreciated! #liverX #livertwitter